An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

A study presented at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).

A point-of-care lung ultrasound system connected to a smartphone combined with a suite of deep learning models outperformed ...

Tuberculosis (TB) is a significant global public health concern. The incidence of extrapulmonary tuberculosis (EPTB) is increasing; however, comprehensive data on its epidemiological and clinical ...

Findings presented at ESCMID Global 2025 highlight the potential of AI-enhanced ultrasound as a frontline diagnostic tool for ...

A study has shown that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).1 ...

This can lower the chances of infection. Tuberculosis can cause severe damage to the lungs, leaving patients with health issues, such as shortness of breath, for years after the infection is cured ...